Test Price
2,300 AEDโ Home Collection Available
Genetic Mapping for Gynecological Disorders Test in UAE | 2300 AED
Executive Summary & Core Metrics
- โAccuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- โPremium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM โ 11 PM).
- โClinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- โInsurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Genetic Mapping for Gynecological Disorders employs high-resolution chromosomal microarray analysis (CMA) with single nucleotide polymorphism (SNP) genotyping to identify clinically relevant copy number variants (CNVs) and loss of heterozygosity (LOH) associated with reproductive system disorders. This test is designed for women seeking in-depth, data-driven insights into conditions such as unexplained infertility, recurrent pregnancy loss, or congenital reproductive anomalies.
| Feature | Our Test (CMA + SNP) | Standard Karyotyping |
|---|---|---|
| Resolution | ~10-20 kilobase (kb) โ detects submicroscopic imbalances | ~5-10 megabases (Mb) โ only large structural changes |
| Methodology | High-density SNP microarray with CNV calling | G-banded chromosome analysis |
| Turnaround Time | 8 weeks | 2โ3 weeks |
| Diagnostic Yield | ~15โ20% incremental yield over karyotyping | ~8โ10% in isolated infertility |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics, I have dedicated my career to interpreting complex genomic data for women with reproductive challenges. We scrutinize every variant in the context of your full clinical picture, ensuring that our findings empower you and your treating physician to make informed decisions. Your privacy and emotional well-being are as important to us as the scientific accuracy of the results.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Exclusion Criteria โ Do Not Book
- Active febrile illness or untreated infection.
- Blood transfusion within the last two weeks.
- Inability to provide informed consent or complete the mandatory Genome Mapping Consent Form (Form 26).
Advisory: Emergency Red Flags
Seek Immediate Medical Attention if you experience:
- Sudden, severe pelvic or abdominal pain.
- Heavy vaginal bleeding with clots or dizziness.
- Signs of systemic infection: fever >38.5ยฐC, chills, rapid heart rate.
Patient FAQ & Clinical Guidance
1. What is genetic mapping for gynecological disorders?
Genetic mapping for gynecological disorders identifies DNA variations linked to reproductive health conditions with high precision. This microarray-based test scans the entire genome for copy number changes that may explain infertility, recurrent miscarriage, or congenital anomalies.
2. How accurate is this genetic test for female infertility?
Our ISO-15189 accredited laboratory achieves a diagnostic sensitivity of 99.9% for clinically relevant genomic imbalances. Accuracy is validated through repeated internal controls and crossโreferencing with international variant databases.
3. Is any special preparation needed before giving the blood sample?
You simply need to complete the mandatory consent form and avoid blood transfusions within two weeks prior to the test. No fasting is required, and our mobile phlebotomy team handles the rest.
UAE Regulatory & Data Privacy Adherence
This service is compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed within a secure, ISOโ9001:2015 accredited environment. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Genetic Mapping for Gynecological Disorders |
| Price (AED) | 2300 AED |
| Turnaround Time | 8 weeks |
| Sample Type / Matrix | Whole Blood (EDTA) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM โ 11 PM) |
| Methodology Used | Chromosomal Microarray Analysis (CMA) with SNP genotyping |
| ICD-10-CM Code | N97.9 (Female infertility, unspecified) |
| LOINC Code | 81258-9 (DNA microarray for copy number variation) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians